Free community. Create a free account to join OppHub America — news, markets, and money angles together. Join free
← Back to Explore

Market context for this story

Loading quotes…

Informational only — not investment advice. Full markets →

OppHub America Desk · · Source: investing-com-stocks

Life Science Stock Shorts: What U.S. Investors Need to Know
Logo mark via Logo.dev · MDXH

Life Science Stock Shorts: What U.S. Investors Need to Know

Share

💡 Monitor short interest changes in MDxHealth ($MDXH), NeoGenomics ($NEO), Bruker Corporation ($BRKR), and Illumina ($ILMN) for potential continued bearish pressure.,Observe Bio-Techne Corporation ($TECH), Tempus AI ($TEM), and Natera ($NTRA) for sustained reductions in short interest, which could indicate improving market sentiment.,Watch the most heavily shorted stocks—WGS, Grail ($GRAL), Tempus AI ($TEM), and Pacific Biosciences ($PACB)—for potential short squeezes or sustained downward trends.

Recent data from TD Cowen reveals significant shifts in short interest for various life science and diagnostic tools companies, offering insights for U.S. investors. Several firms experienced increased short positions, while others saw declines, indicating varied market sentiment within the sector. Understanding these movements can inform investment strategies.

U.S. investors tracking the life science and diagnostic tools sector should note TD Cowen's recent short interest report, which details positions as of July 15. The data highlights substantial changes in bearish bets against several publicly traded companies.

MDxHealth ($MDXH), NeoGenomics ($NEO), Bruker Corporation ($BRKR), and Illumina ($ILMN) experienced the most notable increases in short interest. This suggests a growing sentiment among some investors that these companies' stock prices may decline. Conversely, Bio-Techne Corporation ($TECH), Tempus AI ($TEM), and Natera ($NTRA) recorded the largest decreases in short interest, potentially signaling a more positive outlook from those who had bet against them.

The report also identified the most heavily shorted names in the sector. Whole Genome Sequencing company WGS, Grail ($GRAL), Tempus AI ($TEM), and Pacific Biosciences ($PACB) currently hold the highest levels of short interest. This concentration of short positions could lead to increased volatility for these stocks, as shifts in sentiment or company news might trigger significant price movements.

Based on reporting from investing-com-stocks.

Read the full story

Original reporting and related coverage — attribution links only, not paid recommendations.

Discuss this story

Trade this story

  • Robinhood logoRobinhood
  • Webull logoWebull
  • Tradier logoTradier
  • Interactive Brokers logoIBKR

Chart this story

  • TradingView logoTradingView

Broker and exchange buttons use invite / refer-a-friend links (rewards may be capped). Charting links (TradingView) are partner offers that may pay OppHub America a commission at no extra cost to you.

Curated tools and reads — shopping here helps keep OppHub America free.

Playbook

New stories get a playbook when they publish. Older articles may not have one yet.

No stored playbook for this article. Going forward, playbooks are generated once at publish and kept on the story.

Loading comments...
Share

Follow OppHub America for more money news